NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc.verified

NBY

Price:

$0.0904

Market Cap:

$2.72M

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was former...[Read more]

Industry

Biotechnology

IPO Date

2007-10-26

Stock Exchange

AMEX

Ticker

NBY

The PE Ratio as of April 2024 (TTM) for NovaBay Pharmaceuticals, Inc. (NBY) is -0.02

According to NovaBay Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -92.63% compared to the average of -0.27 of the last 4 quarters.

NovaBay Pharmaceuticals, Inc. (NBY) Historical PE Ratio (quarterly & annually)

How has NBY PE Ratio performed in the past?

The mean historical PE Ratio of NovaBay Pharmaceuticals, Inc. over the last ten years is -2.10. The current -0.02 PE Ratio has changed -4.77% with respect to the historical average. Over the past ten years (40 quarters), NBY's PE Ratio was at its highest in in the December 2017 quarter at 19.91. The PE Ratio was at its lowest in in the March 2022 quarter at -33.42.

Quarterly (TTM)
Annual

Average

-2.10

Median

-2.03

Minimum

-7.97

Maximum

-0.09

NovaBay Pharmaceuticals, Inc. (NBY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NovaBay Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 695.83%

Maximum Annual PE Ratio = -0.09

Minimum Annual Increase = -92.30%

Minimum Annual PE Ratio = -7.97

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.09-53.79%
2022-0.19-92.30%
2021-2.5113.15%
2020-2.2167.69%
2019-1.32-33.89%
2018-2.00-74.93%
2017-7.97238.10%
2016-2.36695.83%
2015-0.30-85.61%
2014-2.06-29.67%

NovaBay Pharmaceuticals, Inc. (NBY) Average PE Ratio

How has NBY PE Ratio performed in the past?

The current PE Ratio of NovaBay Pharmaceuticals, Inc. (NBY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.93

5-year avg

-1.26

10-year avg

-2.10

NovaBay Pharmaceuticals, Inc. (NBY) PE Ratio vs. Peers

How is NBY’s PE Ratio compared to its peers?

NovaBay Pharmaceuticals, Inc.’s PE Ratio is greater than Immix Biopharma, Inc. (-3.56), greater than CNS Pharmaceuticals, Inc. (-0.07), greater than eFFECTOR Therapeutics, Inc. (-0.16), greater than Navidea Biopharmaceuticals, Inc. (-1.57), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.53), greater than ZyVersa Therapeutics, Inc. (-0.03), greater than VectivBio Holding AG (-7.94), less than AVROBIO, Inc. (4.36), greater than Zura Bio Limited (-1.57), greater than Altamira Therapeutics Ltd. (-0.06), greater than Enveric Biosciences, Inc. (-0.14), greater than Palisade Bio, Inc. (-2.56), greater than Phio Pharmaceuticals Corp. (-0.23),

Build a custom stock screener for NovaBay Pharmaceuticals, Inc. (NBY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBay Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovaBay Pharmaceuticals, Inc. (NBY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovaBay Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is NovaBay Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for NovaBay Pharmaceuticals, Inc. (NBY)?

What is the highest PE Ratio for NovaBay Pharmaceuticals, Inc. (NBY)?

What is the 3-year average PE Ratio for NovaBay Pharmaceuticals, Inc. (NBY)?

What is the 5-year average PE Ratio for NovaBay Pharmaceuticals, Inc. (NBY)?

How does the current PE Ratio for NovaBay Pharmaceuticals, Inc. (NBY) compare to its historical average?